Householder Group Estate & Retirement Specialist’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$68K Sell
742
-323
-30% -$29.1K 0.05% 190
2024
Q3
$89K Buy
1,065
+3
+0.3% +$229 0.03% 384
2024
Q2
$72K Buy
1,062
+4
+0.4% +$267 0.02% 413
2024
Q1
$77.5K Buy
1,058
+3
+0.3% +$231 0.02% 392
2023
Q4
$85K Buy
1,055
+587
+125% +$45.7K 0.03% 361
2023
Q3
$35.1K Buy
+468
New +$36K 0.01% 517
2023
Q1
$53K Buy
+642
New +$53.2K 0.02% 435
2022
Q4
Sell
-704
Closed -$43K 613
2022
Q3
$43K Buy
+704
New +$44.4K 0.02% 427

Other funds holding GILD

Householder Group Estate & Retirement Specialist's GILD Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist reduced its Gilead Sciences (GILD) stake by 30% in Q4 2024, selling an estimated $29.1K and leaving 742 shares worth $68K. The position accounts for 0.05% of the portfolio, ranked #190.

Householder Group Estate & Retirement Specialist first reported a position in GILD in Q3 2022 and has held it in 8 quarters since. The position peaked at $89K in Q3 2024. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Householder Group Estate & Retirement Specialist held 742 shares of Gilead Sciences worth $68K as of Q4 2024.
  • Householder Group Estate & Retirement Specialist sold 323 Gilead Sciences shares in Q4 2024, an estimated $29.1K.
  • Gilead Sciences made up 0.05% of Householder Group Estate & Retirement Specialist's portfolio in Q4 2024, its #190 holding.
  • Householder Group Estate & Retirement Specialist first reported a position in Gilead Sciences in Q3 2022 and has held it in 8 quarters since.
  • Householder Group Estate & Retirement Specialist's Gilead Sciences position peaked at $89K in Q3 2024.
  • 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.